1Levitzky YS, Pencina M J, D' Agostino RB, et al. Impact of impaired fasting glucose on cardiovascular disease:the framingham heart study [ J ]. J Am Coil Cardinl, 2008,51 (3) : 264-270.
3Hwang YC, Jee JH, Oh EY, et al. Metabolic syndrome as a predictor of cardiovascular diseases and type 2 diabetes in Koreans [J]. lnt J Cardiol, 2009,134(3 ) :313-321.
4Smith SC Jr. Multiple risk factors ibr cardiovascular disease and dia- betes mellitus[ J ]. Am J Med, 2007,120(3 Soppl 1 ) : S3-S 1 l.
4Miettinen H, Lehto S, Salomaa V, et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care, 1998,21(1) :69-75.
5Haffner SM, Lehto SR,Nnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med, 1998,339(4) :229-234.
6Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J, 2007, 28(1) :88-136.
8Collins R, Armitage J, Parish S, et al. MRC/BHF Heart Proteetion Study of eholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet, 2003,361(9374):2 005-2 016.
9American Diabetes Association. Standards of medical care in diabetes -2006. Diabetes Care, 2006,29(Suppl 1) :S4-S42.
10Garg A,Grundy SM. Management of dyslipidemia in NIDDM. Diabetes Care, 1990,13(2) :153-169.
8Piorkowski M,Fischer S,Stellbaum C,et al.Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?[J].J Am Coll Car-diol,2007,49(10):1035-1042.
9Ge J,Kim YJ,Jang YS,et al.Design and rationale of a study in Asia of atorvastatin pretreatment in patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndromes[J].J Cardiol,2010,55(3):303-308.
10Kendler KSfGardner CO,Fiske A,et al.Major depression and coronary artery disease in the Swedish twin registry: phenotypic,genetic,and environmental sources of comor-bidity[J].Arch Gen Psychiatry,2009,66(8):857-863.
